This release is available in Chinese. An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac ...
The document follows two earlier consensus documents, released in 2013 and 2016. Dominick Angiolillo, MD, PhD (University of Florida College of Medicine – Jacksonville), senior author of the paper, ...
ROME, ITALY — Monitoring platelet function and individualizing antiplatelet therapy did not improve outcomes for elderly ACS patients undergoing coronary stenting, results of the ANTARCTIC trial show ...
November 15, 2009 (Orlando, Florida) — Results for the first head-to-head comparison of different platelet-function tests suggests that a handful of platelet reactivity assays--used to test the ...
WASHINGTON, DC—Additional evidence, this time from a phase IIb trial in healthy people ages 50 to 80, supports that bentracimab (PhaseBio) provides a near-immediate reversal of ticagrelor’s ...
An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...
Ado-trastuzumab emtansine (T-DM1) treatment results in grade 3-4 thrombocytopenia in 8%-13% of patients. Prior in vitro studies reported T-DM1 inhibition of megakaryocyte maturation as the cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback